KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Exchange Rate Effect (2016 - 2025)

AbbVie (ABBV) has disclosed Exchange Rate Effect for 13 consecutive years, with $11.0 million as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect rose 123.91% to $11.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $42.0 million through Dec 2025, up 164.62% year-over-year, with the annual reading at $42.0 million for FY2025, 164.62% up from the prior year.
  • Exchange Rate Effect for Q4 2025 was $11.0 million at AbbVie, up from -$8.0 million in the prior quarter.
  • The five-year high for Exchange Rate Effect was $30.0 million in Q2 2025, with the low at -$59.0 million in Q3 2022.
  • Average Exchange Rate Effect over 5 years is -$8.8 million, with a median of -$8.5 million recorded in 2024.
  • The sharpest move saw Exchange Rate Effect crashed 783.33% in 2021, then soared 433.33% in 2025.
  • Over 5 years, Exchange Rate Effect stood at -$28.0 million in 2021, then soared by 182.14% to $23.0 million in 2022, then changed by 0.0% to $23.0 million in 2023, then crashed by 300.0% to -$46.0 million in 2024, then soared by 123.91% to $11.0 million in 2025.
  • According to Business Quant data, Exchange Rate Effect over the past three periods came in at $11.0 million, -$8.0 million, and $30.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.